Adjusted gross margin was 46.1%, slightly down from 46.6% in Q2 2024 but flat sequentially, and adjusted EBITDA margin was 22%, up 2% year-over-year.
Automation Enabling Technologies segment revenue grew 4% year-over-year, driven by Robotics and Automation business up nearly 16%.
Bookings grew 10% year-over-year and 20% sequentially with a book-to-bill ratio of 1.02, indicating strengthening backlog and outlook.
Gross debt ended at $465 million with a gross leverage ratio of 2.2x and net leverage ratio of approximately 1.7x.
Medical market sales represented 54% of total sales, with advanced industrial markets at 46%.
Medical Solutions segment revenue was roughly flat year-over-year, with Advanced Surgery up 17% and Precision Medicine down 13% year-over-year but up 10% sequentially.
New product revenue grew over 50% year-over-year, with customer orders up 10% year-over-year and 20% sequentially.
Non-GAAP adjusted earnings per share increased 4% to $0.76 in Q2 2025.
Novanta reported second quarter 2025 revenue of $241 million, representing 2% reported growth and a 2% organic decline, surpassing guidance.
Operating cash flow declined to $15 million from $41 million in the prior year quarter, mainly due to timing of tax payments, increased inventory purchases, and the Kion acquisition.
Cash, cash equivalents, and short-term investments totaled $416 million; days sales outstanding was 30 days; inventory days improved to 86 days from 94 days.
GAAP gross margin was 56.1%, non-GAAP gross margin was 56.3%, up 90 basis points sequentially and above guidance midpoint.
GAAP loss per share was $0.67; non-GAAP earnings per share was $0.11, beating guidance midpoint by $0.02.
GAAP operating loss was $23 million; non-GAAP operating income was $1 million.
Home & Life segment revenue was $83 million, up 2% sequentially and 45% year-over-year, led by medical customer ramps and smart home stabilization.
Industrial and Commercial segment revenue was $110 million, up 14% sequentially and 25% year-over-year, driven by electronic shelf labeling, smart meter rollouts, and broad industrial demand.
Silicon Labs reported Q2 revenue of $193 million, up 9% sequentially and 33% year-over-year, in line with guidance midpoint.